The UNC13D gene gives certain immune cells the tools they need to release toxic packets that destroy infected or abnormal cells. This gene plays an important role in keeping the immune response controlled after a threat is recognized. If the UNC13D gene does not work properly, the immune system may stay switched on and cause severe inflammation, often as a condition called familial hemophagocytic lymphohistiocytosis, or HLH. People with harmful variants may develop long fevers, low blood counts, liver or spleen enlargement, and other signs of immune overactivity.
What is a gene?
Genes are segments of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes provide the information needed to make proteins, which are the working parts of cells. Other genes mainly guide when certain processes happen, where they take place, and how active they are. Taken together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, and medications. For a more detailed look at this topic, you can find more in the LearnHub.
Overview
UNC13DGene function
What if the gene works
The UNC13D gene helps certain immune cells release packets of proteins that kill infected or abnormal cells. This supports the body’s ability to control infections and keep immune responses working in a balanced way.
Risk
What if the gene does not work
UNC13D gene variants can cause familial hemophagocytic lymphohistiocytosis type 3, where immune cells cannot control inflammation properly. Depending on whether variants are milder or more severe, symptoms may start earlier or later and range from mild to life threatening.
Treatment
What does that mean for your treatment
Pathogenic variants in the UNC13D gene usually place treatment in the primary HLH pathway, where immune calming treatment is used first and allogeneic stem cell transplant is often the long term treatment. Drug choices can include dexamethasone and etoposide, and some people with refractory, recurrent, or progressive disease may be treated with emapalumab.
Conditions associated with UNC13D
Gene function
What if the gene works
Some immune cells store tiny packets filled with proteins they use to deal with infected or abnormal cells. A key part of normal UNC13D gene function is helping those packets get ready for release and empty at the right moment. This keeps immune responses targeted and controlled.
Inside natural killer cells and killer T cells, the UNC13D gene helps stored packets get ready to be released. Its protein organizes the last steps before these packets can merge with the cell surface.
The UNC13D gene supports the joining of these packet membranes with the outer cell membrane. This lets immune cells empty their contents directly onto the cell they are responding to.
By controlling where and when this release happens, the UNC13D gene helps immune cells act in a precise way. This supports normal immune defense and keeps the response aimed at the right target.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and help explain normal differences among people, such as appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. Sometimes, though, a variant changes how a gene works more substantially and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
UNC13D variants can change the Munc13-4 protein so cells make too little of it, it is unstable, or it cannot help immune cells release their granules properly. This is the key reason how UNC13D variants affect immune cell function. Milder variants may leave some activity, while more severe variants can nearly shut this release system down. That functional range often influences whether hemophagocytic lymphohistiocytosis appears later or earlier and how intense it may be.
How variants are linked to conditions
Pathogenic variants in the UNC13D gene cause familial hemophagocytic lymphohistiocytosis type 3, often called primary HLH. This inherited immune condition can bring episodes of high fever, enlarged liver or spleen, low blood counts, and marked inflammation, often in infancy or childhood, though some people present later. The link between UNC13D gene variants and hemophagocytic lymphohistiocytosis is well established, and finding disease-causing variants in both copies of the gene can confirm the diagnosis.
A variant is not necessarily a diagnosis
Gene variants are a normal feature of human biology, and they are common across the general population. Most do not have a direct effect on health and simply reflect natural human variation. For many genes, carrying a variant associated with a condition points to a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For UNC13D, risk is mainly shaped by whether someone inherits harmful changes in both copies of the gene, which can cause a serious immune condition called familial hemophagocytic lymphohistiocytosis. In people living with this condition, infections, especially viral illnesses, can trigger episodes or make them worse. There is not enough evidence to say lifestyle changes lower this genetic risk.
Inheritance of UNC13D variants
UNC13D-related conditions are inherited in an autosomal recessive pattern. In practical terms, how UNC13D variants are inherited usually means a child must receive one changed copy of the UNC13D gene from each parent to be affected. Parents who each carry one variant are often healthy themselves, and with each pregnancy there is a 25% chance the child inherits both changed copies, a 50% chance the child is a carrier, and a 25% chance the child inherits neither variant. This pattern applies to the well-established UNC13D-related immune condition linked to this gene.
What does my UNC13D result mean for my family?
For families with a disease-causing change in the UNC13D gene, close relatives may also carry the same change, even if they feel well. Brothers and sisters may have the same condition or be carriers, and parents are usually carriers when a child is affected. Other relatives may also want to learn whether they carry the family’s UNC13D change.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a UNC13D variant, genetic testing for UNC13D variants usually analyzes DNA from a blood sample or saliva. This test reads the UNC13D gene for spelling changes and may also check for missing or extra pieces, which can help confirm an inherited immune condition when your symptoms and lab results fit.
When should I consider getting a genetic test?
Consider UNC13D genetic testing if someone has had episodes of severe immune overreaction with ongoing fever, an enlarged liver or spleen, low blood counts, or a diagnosis of hemophagocytic lymphohistiocytosis (HLH). Testing can also help when HLH runs in the family or when a child has unexplained, severe inflammation.
A genetic result is only one part of your health story
A genetic result can provide useful information, but how much it reveals depends on the condition and the kind of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, also influence how the body works. In some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is most helpful when considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can also help put personal experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment works well for one person, seems weaker for another, or causes more side effects in someone else. Small inherited differences can change how the body breaks down, moves, or responds to a drug, and this kind of variation is common.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes affect their response to medications. By looking at relationships between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body processes it. This information can support treatment decisions that are more informed and more individualized. You can learn more about this topic in the LearnHub.
Drugs influenced by the UNC13D gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work, so any concerns about side effects, unusual reactions, or treatment response are best discussed with your doctor.
History
UNC13D entered medical genetics through research on families affected by inherited hemophagocytic lymphohistiocytosis, now often called familial HLH. In the early 2000s, scientists used family linkage studies to narrow the search to a region on chromosome 17. Building on this early work, researchers identified disease causing variants in the UNC13D gene and recognized this form as familial HLH type 3. That finding helped separate one inherited cause from other conditions that can look similar in the clinic. Over time, descriptions became more precise as additional families and variant patterns were reported from different countries. This history gave doctors a clearer way to classify inherited HLH and connect severe immune overactivation with a specific genetic cause.